N‑Acetylcysteine (NAC) Therapy in Acute Liver Failure

1. Dosing Protocols

• Intravenous 21‑hour NAC regimen (FDA‑approved): loading dose 150 mg/kg over 15 min, second dose 50 mg/kg over 4 h, and third dose 100 mg/kg over 16 h, totaling 300 mg/kg. 1
• Oral NAC alternative (when IV access unavailable): loading dose 140 mg/kg given orally or via nasogastric tube (diluted to a 5 % solution), followed by 70 mg/kg every 4 h for 17 additional doses. 4
• Limitations of oral route: often contraindicated in ALF patients with active gastrointestinal bleeding, worsening mental status, or encephalopathy. 1

2. Indications for Acetaminophen‑Induced ALF

• Immediate NAC initiation is recommended whenever acetaminophen overdose is known or suspected, toxic serum levels are present (even if ingestion was remote), rising aminotransferases suggest evolving injury, or the clinical context is unclear. 1
• Do not wait for acetaminophen level results before starting NAC. 5
• Activated charcoal (1 g/kg orally) should be given if presentation occurs ≤ 4 h after ingestion, without reducing NAC efficacy and potentially beneficial up to 3–4 h post‑ingestion. 1

3. NAC in Non‑Acetaminophen ALF

• Guideline recommendation: The 2020 French guidelines give a GRADE 2+ recommendation for NAC use in all etiologies of acute liver failure. 5
• Evidence quality: Evidence for benefit in non‑acetaminophen ALF is of lower quality than that for acetaminophen toxicity. 8

4. Clinical Outcomes (Meta‑analysis)

Both outcomes demonstrate statistically significant improvement with NAC. 8

• Reduced progression to severe encephalopathy (grade III‑IV): 40 % vs 68 % (p = 0.047). 9
• Lower vasopressor requirement: 48 % vs 80 % (p = 0.018). 8
• Fewer bleeding complications reported with NAC therapy. 3

5. Timing of Initiation

• NAC provides the greatest benefit when started early, particularly in patients with grade I‑II hepatic encephalopathy; efficacy diminishes as encephalopathy advances. 8

6. Safety and Adverse Effects

• Mild adverse events: occasional nausea/vomiting, transient bronchospasm (1‑2 % incidence), and urticaria/facial flushing. 4
• Serious hypersensitivity (anaphylactoid) reactions may occur 30‑60 min after infusion start, presenting with rash, hypotension, wheezing, and dyspnea. 5
• Management of severe reactions: immediately stop the infusion and administer antihistamines; epinephrine is indicated for bronchospasm. 4

7. Monitoring During Therapy

• Laboratory monitoring: serial hepatic enzymes (AST, ALT), bilirubin, glucose, and arterial lactate levels. [3][1]

8. Supportive Care and Transplant Referral

• Early transplant center contact is advised for every ALF patient to assess transplant candidacy and arrange potential transfer. 1
• ICU admission is mandatory for all ALF cases, with continuous monitoring and supportive measures including management of encephalopathy and prevention of cerebral edema. [4][8]

9. Practical Pitfall

• Do not delay NAC while awaiting diagnostic confirmation in suspected acetaminophen overdose; AASLD guidelines explicitly state NAC should be administered immediately regardless of serum level results. [5][1]

All facts are derived from cited references and reflect current guideline recommendations and evidence levels where specified.